Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in patients with autoimmune diseases 9193
Abstract Description Autoreactive CD4+ cells control the immune response in chronic autoimmune diseases but remain difficult to track. The ex vivo characterization of autoreactive T cells is essential to understand their function and how they adapt to chronic autoimmunity. Neuromyelitis optica spectrum disorder is a prototypic autoimmune disease of the central nervous system targeting aquaporin-4 (AQP4). AQP4-specific CD4+ T cells are centrally involved in disease development. However, their functional and molecular properties are poorly characterized. We combined HLA-tetramer- and antigen-reactive T cell enrichment and scRNA sequencing to characterize ex vivo AQP4-specific CD4+ T cells isolated from blood of patients and healthy donors. Surprisingly, in AQP4-antibody+ NMOSD patients, autoreactive T cells showed reduced proliferative capacity and pro-inflammatory cytokines. Instead, exhaustion-associated co-inhibitory receptors were co-expressed together with FOXP3. The proliferative blockade of autoreactive T cells was reversed in vitro by checkpoint inhibition. The same exhaustion-like phenotype was demonstrated in autoimmune hepatitis and bullous pemphigoid. We identified a new exhaustion-like T cell phenotype and a potential role of FOXP3 for the regulation of chronic autoreactivity in human autoimmune disease. Our data suggest CD4+ T cell exhaustion as a common mechanism of adaptation to chronic self-stimulation across disease types with important implications for their therapeutic targeting Topic Categories Basic Autoimmunity (BA)
Authors
- Kilian Schober (ORCID: https://orcid.org/0000-0001-9323-9472)
- Johannes Hartl (ORCID: https://orcid.org/0000-0002-4037-9938)
- Frank Leypoldt (ORCID: https://orcid.org/0000-0002-8972-515X)
- Petra Bächer (ORCID: https://orcid.org/0000-0003-4264-6451)
- Simon Fillatreau (ORCID: https://orcid.org/0000-0002-7730-9917)
- Andreas Hutloff (ORCID: https://orcid.org/0000-0002-0572-8151)
- Daniela Esser
- Carina Saggau
- Alexander Scheffold (ORCID: https://orcid.org/0000-0002-0626-343X)
- Marek Wieczorek (ORCID: https://orcid.org/0000-0002-0862-8076)
- Friedemann Paul (ORCID: https://orcid.org/0000-0002-6378-0070)
- Gabriela Rios Martini
- Dirk Hans Busch (ORCID: https://orcid.org/0000-0001-8713-093X)
- Sarah-Sophie Schacht (ORCID: https://orcid.org/0000-0003-2512-1741)
- Justina Dargvainiene (ORCID: https://orcid.org/0009-0002-4114-3748)
- Julia Polansky-Biskup
- Roland M. Martin
- Nora Kohlstedt
- Mahdi Rasa
- Nicola Mohr
- Klarissa H. Strner
Institutions
- University Medical Center (US)
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital and Clinics (US)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.2629
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00